Nevertheless, CD64 tracers could potentially be used to study other (chronic) inflammatory conditions in which CD64+ cells play a prominent role such as osteoarthritis, inflammatory bowel diseases [41] and SLE [42] once diagnosed. Here, FCGR1A is linked to systemic lupus erythematosus.